Therapeutic Potential and Utility of Elacridar with Respect to P-glycoprotein Inhibition: An Insight from the Published In Vitro, Preclinical and Clinical Studies-Reference-Cited by-同舟云学术

Therapeutic Potential and Utility of Elacridar with Respect to P-glycoprotein Inhibition: An Insight from the Published In Vitro, Preclinical and Clinical Studies

Published:2017-04-03 Issue:6 Volume:42 Page:915-933
ISSN:0378-7966
Container-title:European Journal of Drug Metabolism and Pharmacokinetics
language:en
Short-container-title:Eur J Drug Metab Pharmacokinet

Author:

Dash Ranjeet Prasad,Jayachandra Babu R.,Srinivas Nuggehally R.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

http://link.springer.com/article/10.1007/s13318-017-0411-4/fulltext.html

Reference116 articles.

1. Russel FGM (2010) Transporters: Importance in drug absorption, distribution, and removal. In: Pang K, Sandy, Rodrigues, A. David, Peter, Raimund M (eds) In Enzyme- and transporter-based drug–drug interactions. Springer: New York

2. Varma MV, Ashokraj Y, Dey CS, Panchagnula R. P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement. Pharmacol Res. 2003;48:347–59. doi: 10.1016/S1043-6618(03)00158-0 .

3. Fredriksson R, Nordstrom KJ, Stephansson O, Hagglund MG, Schioth HB. The solute carrier (SLC) complement of the human genome: phylogenetic classification reveals four major families. FEBS Lett. 2008;582:3811–6. doi: 10.1016/j.febslet.2008.10.016 .

4. Mukhopadhyay T, Batsakis JG, Kuo MT. Expression of the mdr (P-glycoprotein) gene in Chinese hamster digestive tracts. J Natl Cancer Inst. 1998;80:269–75. doi: 10.1093/jnci/80.4.269 .

5. Demeule M, Labelle M, Regina A, Berthelet F, Beliveau R. Isolation of endothelial cells from brain, lung, and kidney: expression of the multidrug resistance P-glycoprotein isoforms. Biochem Biophys Res Commun. 2001;281:827–34. doi: 10.1006/bbrc.2001.4312 .

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and validation of an LC-MS/MS method for simultaneous quantification of eight drugs in plasma and brain: Application in a pharmacokinetic study in mice;Journal of Chromatography B;2024-09

2. P-glycoprotein (P-gp)-driven cancer drug resistance: biological profile, non-coding RNAs, drugs and nanomodulators;Drug Discovery Today;2024-09

3. Overcoming ABCB1 mediated multidrug resistance in castration resistant prostate cancer;Cell Death & Disease;2024-08-01

4. An all-in-one nanoparticle for overcoming drug resistance: doxorubicin and elacridar co-loaded folate receptor targeted PLGA/MSN hybrid nanoparticles;Journal of Drug Targeting;2024-07-05

5. Design and synthesis of BMH-21-like quinazolinone derivatives as potential anti-cancer agents;Journal of Molecular Structure;2024-07